1. Home
  2. IBRX vs CPB Comparison

IBRX vs CPB Comparison

Compare IBRX & CPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$7.54

Market Cap

7.2B

Sector

Health Care

ML Signal

HOLD

Logo Campbell Soup Company

CPB

Campbell Soup Company

HOLD

Current Price

$22.03

Market Cap

6.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
IBRX
CPB
Founded
2014
1869
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
7.2B
6.6B
IPO Year
2015
1994

Fundamental Metrics

Financial Performance
Metric
IBRX
CPB
Price
$7.54
$22.03
Analyst Decision
Strong Buy
Hold
Analyst Count
7
18
Target Price
$12.57
$26.06
AVG Volume (30 Days)
12.2M
9.7M
Earning Date
05-08-2026
06-01-2026
Dividend Yield
N/A
7.63%
EPS Growth
38.71
6.35
EPS
N/A
1.55
Revenue
$113,288,000.00
$10,253,000,000.00
Revenue This Year
$88.59
N/A
Revenue Next Year
$131.15
$0.11
P/E Ratio
N/A
$14.41
Revenue Growth
668.31
6.40
52 Week Low
$1.95
$19.56
52 Week High
$12.43
$34.18

Technical Indicators

Market Signals
Indicator
IBRX
CPB
Relative Strength Index (RSI) 44.85 49.38
Support Level $6.69 $20.16
Resistance Level $8.54 $22.85
Average True Range (ATR) 0.54 0.79
MACD -0.12 -0.07
Stochastic Oscillator 12.61 27.21

Price Performance

Historical Comparison
IBRX
CPB

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

About CPB Campbell Soup Company

Over the past 150-plus years, Campbell's has evolved into a leading domestic packaged food manufacturer, with a portfolio that extends beyond its iconic red-and-white labeled canned soup. In fiscal 2025 (July year-end), snacks accounted for 43% of its revenue, followed by soup (27%), other simple meals (23%), and beverages (7%). Beyond its namesake, its brands include Pepperidge Farm, Goldfish, Snyder's of Hanover, Swanson, Pacific Foods, Prego, Pace, V8, and, most recently, Rao's (a deal that closed in 2024). Around 90% of its revenue results from the US and the remainder from Canada and Latin America.

Share on Social Networks: